The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Iberdomide (Iber) maintenance following upfront autologous stem cell transplant (ASCT) in multiple myeloma (MM).
 
Tanya Wildes
Honoraria - Carevive Systems
Consulting or Advisory Role - Carevive Systems; Janssen Oncology; Pfizer; Sanofi; Seagen
Research Funding - Janssen Oncology; Janssen Oncology (Inst)
 
Vera Suman
No Relationships to Disclose
 
Jens Hillengass
Employment - Roswell Park Cancer Institute
Honoraria - BeiGene; Cancer Network; IntegrityCE; Janssen Biotech; Targeted Oncology; The Binding Site
Consulting or Advisory Role - Angitia; Bristol-Myers Squibb/Celgene; Janssen Biotech; Pfizer; Prothena; Regeneron; Regeneron; Sebia; Siemens Healthineers
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Celgene (Inst); GlaxoSmithKline (Inst)
Patents, Royalties, Other Intellectual Property - “Discovering anti-CXCR2 inhibitor alone or in combination with standard of care for the treatment of multiple myeloma” – RP23-023/809466-01 US provisional patent application 63/546,942
 
Joseph Tario
No Relationships to Disclose
 
Sarah Holstein
Research Funding - Bristol-Myers Squibb/Celgene (Inst)